Seidman Cancer Center
Showing of 54 results
Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
Study is being done through an agreement between UH and Luminary Therapeutics.
UH Seidman Cancer Center Offers Patients Rare Access to New Kidney Cancer Tracer
UH Seidman Cancer Center is one of just a few cancer centers nationwide to offer its patients early access to a novel and more sensitive method of diagnosing kidney cancer.
University Hospitals Researcher and Team Awarded $2.78M Federal Grant to Improve Rectal Cancer Treatment with Artificial Intelligence
Co- Principal investigator, Dr. Emily Steinhagen, from UH Seidman Cancer Center leads the team with colleagues from the radiology, pathology, oncology, biostatistics and surgery departments at CWRU, Cleveland Clinic, UH and Medical College Wisconsin.
International Leader in Cancer Research at University Hospitals Seidman Cancer Center Passes Away
Nathan Berger, MD, Ph.D was Chief of the Hematology and Oncology Division of University Hospitals.
UH Seidman Cancer Center Researchers Awarded ASCO Young Investigator Awards
James Ignatz-Hoover, MD, PhD and Courtney Pisano, DO, MS, MPH will each receive $50,000 research funding from The American Society of Clinical Oncology for their respective research projects in clinical oncology.
UH First Health System in Northeast Ohio to Widely Offer Galleri®, a Multi-cancer Early Detection Blood Test Designed to Screen for More Than 50 Types of Cancer
UH planning multiple screening events with first responders throughout region – including the first with the city of Highland Heights.
University Hospitals Physician-scientist, Linda Cummings, Selected for American Gastroenterological Association Pilot Research Award
Research will address growing problem of antimicrobial resistance in eradicating Helicobacter Pylori (H. pylori), a bacterial infection that increases the risk of gastric cancer and peptic ulcer disease.
Novel Oral Hormone Therapy Shows Promising Results for Prostate Cancer Treatment with Radiation Therapy
A high impact study led by Daniel Spratt, MD, demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.